Inspire Medical Systems Inc (INSP) - Total Assets
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) holds total assets worth $911.38 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check INSP cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Inspire Medical Systems Inc - Total Assets Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Inspire Medical Systems Inc to see how much of total assets are deployed in long-term investments.
Inspire Medical Systems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Inspire Medical Systems Inc's total assets of $911.38 Million consist of 64.3% current assets and 35.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.6% |
| Accounts Receivable | $119.69 Million | 13.2% |
| Inventory | $145.29 Million | 16.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INSP company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inspire Medical Systems Inc's current assets represent 64.3% of total assets in 2025, a decrease from 93.4% in 2016.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2025, down from 51.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 16.0% of total assets.
Inspire Medical Systems Inc Competitors by Total Assets
Key competitors of Inspire Medical Systems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥2.53 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
Inspire Medical Systems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.34 | 9.01 | 10.25 |
| Quick Ratio | 4.48 | 7.44 | 9.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $477.40 Million | $508.21 Million | $225.14 Million |
Inspire Medical Systems Inc - Advanced Valuation Insights
This section examines the relationship between Inspire Medical Systems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.54 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | 12.2% |
| Total Assets | $907.32 Million |
| Market Capitalization | $1.22 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Inspire Medical Systems Inc's assets above their book value (1.34x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Inspire Medical Systems Inc's assets grew by 12.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual total assets of Inspire Medical Systems Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $907.32 Million | +12.24% |
| 2024-12-31 | $808.38 Million | +19.44% |
| 2023-12-31 | $676.81 Million | +19.82% |
| 2022-12-31 | $564.88 Million | +91.43% |
| 2021-12-31 | $295.08 Million | +4.94% |
| 2020-12-31 | $281.19 Million | +55.14% |
| 2019-12-31 | $181.25 Million | -9.41% |
| 2018-12-31 | $200.08 Million | +697.42% |
| 2017-12-31 | $25.09 Million | +91.30% |
| 2016-12-31 | $13.12 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more